UroGen Pharma (URGN) PT Lowered to $45 at Jefferies
Tweet Send to a Friend
Jefferies analyst Chris Howerton lowered the price target on UroGen Pharma (NASDAQ: URGN) to $45.00 (from $55.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
